Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

August 10, 2021

Immunovia Provides Updates on the Price for the IMMray[TM] PanCan-d Test in the US and Improved Test Performance in the Familial/Hereditary Risk Group

Read press release
August 4, 2021

Immunovia, Inc. Receives Approval to Begin Testing Patients for Pancreatic Cancer with the IMMray™ PanCan-d Test

Read press release
June 30, 2021

Immunovia, Inc. Receives Certificate of Registration – Clinical Laboratory Licensure Still Pending

Read press release
May 28, 2021

CEO Patrik Dahlen purchases Immunovia shares

Read press release
May 27, 2021

Immunovia to Host a Key Opinion Leader Event on the Clinical Use of IMMray™ PanCan-d

Read press release
May 12, 2021

Member of Immunovia’s Board of Directors purchases shares in the company

Read press release
May 6, 2021 | REGULATORY

Annual General Meeting – Immunovia AB

Read press release
May 4, 2021

Members of Immunovia’s Board of Directors purchase shares in the company

Read press release
April 28, 2021 | REGULATORY

Immunovia Reports Interim Report January – March 2021

Read press release
April 22, 2021

Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test

Read press release
April 21, 2021 | REGULATORY

Immunovia presents update on US market size for IMMray™ PanCan-d in the familial/hereditary risk group

Read press release
April 21, 2021

Invitation to Presentation of Immunovia’s Interim Report January – March 2021

Read press release
1 … 7 8 9 10 11 … 27
Home Press releases Page 9